(With reporting from EurekAlert.org)
A new, long-term study of the most popular osteoporosis drug, Fosamax or alendronate sodium, has found extended fracture relief for women who have taken the drug for five years. After that time period has elapsed, women with osteoporosis can discontinue drug use without increasing their fracture risk for as long as five more years after stopping treatment.
Researchers from the University of California, San Francisco, published their study on Fosamax...
Read moreMany would argue that back pain is inevitable and for some it becomes a sudden reality. Bending over to pick up a piece of paper, moving... Read more »
Spondylolisthesis (spaun-di-lo-lie-thee-sis) is a mouthful and is a common cause of low back pain (although it can exist anywhere in the... Read more »
Driving a car to the local mechanic to get it fixed is not the same thing as taking the human body into surgery; although, this "fix-it"... Read more »
How can chronic pain be prevented? Oh that I and the insurance companies knew the answer to that question! The key is to identify those... Read more »
Last month, the American Pain Society added to its recommendations to health care providers regarding the diagnosis and treatment of low... Read more »
This is a study to evaluate the level of pain control and safety of different doses of a new extended-release pain med (CG5503) in people with... Read more »
This is a study to determine the safety and effectiveness of a new transdermal pain med in patients with chronic lower back pain. This national study... Read more »
According to a new study, practicing yoga may help decrease lower back pain. Read more »
Australian researchers say even very severe back pain is unlikely to mean the sufferer has a more serious health issue such as a broken vertebrae or... Read more »
This is a study to see if Celebrex is as effective as Ultram for patients with chronic lower back pain. This national study is currently recruiting... Read more »